Introduction
============

Electrospinning and tissue engineering scaffolds
------------------------------------------------

Electrospinning, which is an ultrafine fiber manufacturing technology, was coined in the 1990's from the earlier used term of "electrostatic spinning" ([@b29-ijn-2-623]) by Reneker and co-workers ([@b22-ijn-2-623]; [@b74-ijn-2-623]). It has now attracted increasingly worldwide attention in both the academic community and industrial world ([@b74-ijn-2-623]; [@b35-ijn-2-623]; [@b56-ijn-2-623]). Electrospinning is capable of fabricating fibers with nanometer scale diameters that yield very high specific surface area -- up to one to two orders of magnitude higher than micrometer scale fibers produced by conventional melting and dry/wet spinning methods. Electrospun nanofibers are therefore very useful for developing a variety of products or structures whose functional efficiency is surface area dependent. Among those potential applications proposed ([@b35-ijn-2-623]; [@b56-ijn-2-623]; [@b101-ijn-2-623]), construction of biomimetic[1](#fn1-ijn-2-623){ref-type="fn"} cellular scaffold will represent one of the most promising applications for the electrospun nanofibers. Using 'Electrospinning' as the keyword for literature searching through the ISI Web of Science^®^, it was found that, of the top 10 most cited articles[2](#fn2-ijn-2-623){ref-type="fn"} out of more than 1000 relevant papers, 3 of them pertain to the subject of nanofibrous tissue scaffolding applications with the other 7 articles being either reviews or related to the process of electrospinning. The underlying rationale of using nanofibers for constructing cellular scaffolds is based on the biomimesis principle that electrospun nanofibers can mimic the physical structure of the major constructive elements in the native ECM as biologically, almost all of the tissues and organs such as bone, skin, tendon and cartilage, are synthesized and hierarchically organized into fibrous form (structure) with fiber dimensions down to nanometer scale ([@b69-ijn-2-623]; [@b44-ijn-2-623]). Nanofibrous scaffold could therefore provide environmental or physical cues to the cells and promote cell growth and function well towards the synthesis of genuine extracellular matrices over time ([@b54-ijn-2-623]). Unlike other types of architectural scaffolds, using electrospun nanofiber for scaffolding implies that while the nanofibrous scaffold is responsible for the overall mechanical properties of the tissue or cell-scaffold complex, the nanolevel structures (nanofibers) can provide nanomechanical and biodegradation properties for cells to proactively interplay with the provisional matrix and functionalize and remodel it, similar to that of the native cellular remodeling process within the ECM.

Thus, electrospinning has recently established the reputation for its capability to make ECM-mimicking scaffolds, and is counted as a new addition to the conventional scaffold fabrication techniques (eg, solvent-casting and particulateleaching, gas foaming, fiber bonding, freeze drying, etc). However, despite the increasing interest in electrospinning for the past decade, making use of electrospun nanofibers for tissue engineering has only a mere short history of about 5--7 years ([@b28-ijn-2-623]; [@b86-ijn-2-623]; [@b60-ijn-2-623]). Both the design, fabrication of the nanofibrous scaffolds and molecular level understanding of the interactions *in vitro* between the nanofibrous scaffolds and mammalian cells as well as *in vivo* tests and applications are still in the early stage of development. With respect to the materials used in electrospinning in the very first few years since 2001, traditional synthetic biodegradable aliphatic polyesters such as PLA, PLGA, and PCL are still the preferred and prevailing choices of materials for constructing nanofibrous scaffolds due to their well-known good processability and mechanical performance. Obviously, in the context of biomimicking nanoscale fibers, these electrospun synthetic polymers have replicated the physical dimensions and morphology of the major component collagen in the native ECM. Yet, two persistent problems can restrain the synthetic polymeric nanofibers from being effective during application. Firstly, unlike natural biopolymers, the pristine synthetic polymers lack cell recognition sites on the scaffold surfaces and that means poor cell affinity ([@b36-ijn-2-623]; [@b8-ijn-2-623]; [@b76-ijn-2-623]). Secondly, the aggravated hydrophobicity arising from their inherent hydrophobic attribute ([@b12-ijn-2-623]; [@b7-ijn-2-623]) and nanoscale effect ([@b27-ijn-2-623]; [@b68-ijn-2-623]) will affect cell seeding on the nanofibrous scaffolds and subsequent cellular activities. In addition, their acidic degradation products have detrimental effects to the cells. Hence, despite the scaffold being porous and possessing higher surface area, poor hydrophilicity will cause a majority of the pores to remain empty, potentially resulting in the underutilization of the 3-D scaffolds. These are certainly the immediate problems to be addressed prior to effective use.

Why composite nanofibers?
-------------------------

The above noted problems demand for the development of bioactive[3](#fn3-ijn-2-623){ref-type="fn"} and functional electrospun nanofibers. Essentially, it is related to the biochemical attributes of the used materials. The most ideal candidate materials should be the native biomaterials such as collagen. However, one of the shortcomings for collagen is its inadequate mechanical properties after being processed from its native form. Thus, an alternative solution will be to make appropriate modification to the synthetic polymers. Whilst traditional surface chemical modification approaches used on the bulk synthetic polymers can be applied to ameliorate the synthetic nanofibers, simple physical hybridizing synthetic polymers with bioactive natural biopolymers and then converting the hybrids into nanofibers will offer a more facile and cost-effective route for modifying and tailoring the material properties. By definition, composite materials or composites are made from two or more components. As natural and synthetic polymers constitute the largest fraction of biomaterials for tissue scaffolding, here we will define a composite fiber as one whose materials are compounded from one synthetic sourced polymer and one from natural sourced polymer or inorganic nanoparticles. Unlike traditional engineering composites where inorganic components such as carbon and glass fibers are used to reinforce the matrix material, the natural biopolymers used are to impart bioactivity to the biologically passive synthetic polymers. With the versatile electrospinning, such composite nanofibers can be designed and fabricated in the form of either basically random blending or ordered structure (eg, core-sheath) from the available synthetic and natural polymers. A number of merits are conceivable with such composite nanofibers. Physically, the new composite nanofibers could provide better hydrophilicity (wettability) and improved mechanical properties, etc. Biologically, the incorporation of bioactive macromolecules (eg, collagenous proteins or growth factors) into the synthetic components could promote cell-surface recognition and also promote or control many aspects of cell physiology such as adhesion, spreading, activation, migration, proliferation and differentiation ([@b23-ijn-2-623]). Due to the size of the nanofibers, such effects are being augmented or made more effective because of the high surface area for cells to access. Additionally, as controlled and sustained delivery of growth factors are deemed necessary for successful tissue engineering ([@b2-ijn-2-623]; [@b37-ijn-2-623]), the biomimetic composite nanofibers, in particular, core-sheath structure could perform controlled and effective delivery of bioactive molecules purely from the nanofibrous scaffolds without using extra delivery devices.

Here, we will focus on composite nanofibrous scaffolds primarily made from biodegradable synthetic and natural materials. Using a binary hybridizing system as an illustration, composite nanofibers in the forms of randomly blended structure, core-shell structure, and mingled nanofibers ([Figure 1](#f1-ijn-2-623){ref-type="fig"}) will be the major three types of composite nanofibers discussed. Since composites involve different phases, the illustrations in [Figure 1](#f1-ijn-2-623){ref-type="fig"} also reflect the typical different phase separation or existence states in a biphasic structured composites or hybrid nanofibers.

Components blended composite nanofibrous scaffolds
==================================================

The components blended composite nanofibers can be divided into two categories, ie, organic-organic blends and organic-inorganic blends. Both will be discussed in the following two sub-sections.

Organic-organic blends
----------------------

As mentioned above, the organic-organic blends is meant to be made from synthetic and natural sourced polymers with improving bioactivity and functions as the chief concern. [Table 1](#t1-ijn-2-623){ref-type="table"} gives a summary of organic-organic blend nanofibrous scaffolds which have been explored by different researchers. As one of the earliest groups of applying the composite concept for developing biomimetic and bioactive nanofibrous scaffolds, we have demonstrated the efficacy of using a combination of the natural collagen-derived biopolymer gelatin (Gt) with the synthetic poly(ɛ-caprolactone) (PCL) to acquire desired physical, chemical and biological properties of nanofibrous scaffolds ([@b101-ijn-2-623]). Our results showed that composite nanofibrous scaffold Gt/PCL had very good wettability and/or hydrophilicity and balanced mechanical properties compared to its constituents. *In vitro* cell culture experiments manifested very significant cell proliferation and infiltration compared to the biologically inert synthetic PCL alone scaffolds. Cellular infiltration into the Gt/PCL composite nanofibrous scaffolds up to 110 μm was, for the first time, quantitatively measured through a laser scanning microscopy. The favorable cellular responses were attributed to the materials hybridization effect. Introduction of the bioactive biopolymer of Gt into the PCL had remarkably improved the wettability and cell affinity of the fibrous scaffolds. Although electrospun nanofibrous scaffolds are deemed porous with interstices formed by fiber interlacing, the 'pores' formed would be much smaller than the normal cell size of a few to tens of microns which could inhibit cell migration to the interior of the electrospun nanofibrous structure. Nevertheless, we speculate that three factors could be responsible for the observed cellular infiltration phenomenon. Firstly, the introduction of natural biopolymer of Gt into the PCL confers good hydrophilicity/wettability and biological recognition signals, which will consequently facilitate nutrients/oxygen transfer and removal of metabolic products and encourage pioneering cells to migrate deeper into the scaffold. Such a favorable local microenvironment as a result of material constituents can definitely modulate the cellular responsive behaviour ([@b13-ijn-2-623]; [@b18-ijn-2-623]; [@b88-ijn-2-623]). Secondly, Gt/PCL composites had lower tensile strength, but very good elongation and deformation properties. These favorable mechanical properties can provide easier opening of spaces for cell penetration to deeper levels of the scaffold. Matched nanomechanical properties will be one of the important factors to account for cell penetration. The resilience and deformability of scaffolds at nano-, meso-, and macro-scale do influence *in vitro* migration and morphology of cells ([@b9-ijn-2-623]). Lastly, the gelatin component in the Gt/PCL scaffold is gradually dissolved during cell culture resulting in the emergence of porous fibers. This will in situ make extra space for cell migration and easy transportations of nutrients and waste. The formation of 3-D porous fibers was demonstrated in our later study ([@b99-ijn-2-623]) by leaching the gelatin component out of the composite fibers as shown in [Figure 2](#f2-ijn-2-623){ref-type="fig"}. The 3-D porous fiber morphology also suggests that the phase separation of gelatin and PCL in the composite nanofibers is in a randomly blended fashion. Further, BET surface area measurement indicated that the 3-D porous fibers possessed a surface area of about 2.4 times that of the pristine Gt/PCL fibers. With these encouraging results, very recently we have electrospun Gt/PCL composite nanofibers onto a polyurethane dressing (Tegaderm™, 3M Medical) for potential dermal wound healing application ([@b16-ijn-2-623]). Significant cell adhesion, growth and proliferation on the Tegaderm-nanofiber construct were achieved, providing great potential and feasibility in the treatment of wounds through layered dermal reconstitution. In another study using a similar strategy, [@b55-ijn-2-623]) also fabricated gelatin-containing composite nanofibrous scaffolds of PLGA/gelatin/elastin for potential soft tissue engineering applications. The cultured H9c2 rat cardiac myoblasts and rat bone marrow stromal cells (BMSCs) were found to grow well and cell penetration into the scaffolds were also observed through histological characterization. These studies also indicate that as the bioactive component of gelatin is a hydrogel dissolvable in water, blending gelatin with a structural stable synthetic polymer to form composites circumvents the chemical cross-linking related cytotoxicity problem of gelatin scaffolds ([@b99-ijn-2-623]).

It is also noted that many investigations are based on the collagen/synthetics blends to produce biomimetic and bioactive scaffolds. Bioactivity and/or biofunctions have been remarkably achieved in the nanofibrous form. These studies have similarly demonstrated that compared to the synthetic nanofibrous counterparts, collagen-containing composite nanofibrous scaffolds facilitated cell adhesion ([@b84-ijn-2-623]; [@b52-ijn-2-623]; [@b55-ijn-2-623]; [@b70-ijn-2-623]; [@b93-ijn-2-623]; [@b67-ijn-2-623]; [@b80-ijn-2-623]), spreading ([@b31-ijn-2-623]; [@b52-ijn-2-623]; [@b93-ijn-2-623]), viability ([@b31-ijn-2-623]; [@b80-ijn-2-623]), migration ([@b84-ijn-2-623]; [@b81-ijn-2-623]; [@b80-ijn-2-623]), proliferation ([@b84-ijn-2-623]; [@b52-ijn-2-623]; [@b93-ijn-2-623]; [@b67-ijn-2-623]; [@b80-ijn-2-623]), phenotypic morphological preservation and differentiation ([@b31-ijn-2-623]; [@b80-ijn-2-623]), and possible collagenase degradation function ([@b84-ijn-2-623]). In addition, introduction of collagen in processing can facilitate the generation of even finer electrospun fibers ([@b52-ijn-2-623]; [@b55-ijn-2-623]; [@b55-ijn-2-623]; [@b70-ijn-2-623]; [@b93-ijn-2-623]). Apart from these gelatin/collagen/elastin-containing composite nanofibrous scaffolds, in a different strategy, Li et al fabricated polyaniline (PANi)-contained gelatin composite nanofibrous scaffolds by doping gelatin with a small amount of conductive polymer PANi and demonstrated biocompatibility of such conductive nanofibrous scaffolds ([@b55-ijn-2-623]). This groundwork will prompt future probing of the electroactive effect of such scaffolds for engineering cardiac or neuronal tissues. In another study, for even better mimicking of the natural ECM which is mainly composed of collagen and glycosaminoglycans (GAGs), Zhong et al prepared collagen/condroitin sulfates composite nanofibrous scaffolds and demonstrated their excellent biocompatibility through conducting *in vitro* culturing of rabbit conjunctive fibroblasts on the developed scaffolds ([@b107-ijn-2-623]).

Although the above attempts of introducing natural materials have resulted in improved biological properties, there appeared some biophysical and mechanical inadequacies with these systems. One of the noted problems is the dissolving solvent which implicates modification to the natural biopolymer structure. As seen in [Table 1](#t1-ijn-2-623){ref-type="table"}, except work by [@b6-ijn-2-623] where aqueous acidic solutions were used for electrospinning collagen/elastin/PEO blends, almost all the other composite nanofibers produced employed the strong polarity organic solvent of fluorinated alcohols, in particular the HFIP as the dissolving solvent. The reason is that to have the blend of collagen/synthetics successfully electrospun, selecting an organic solvent which is capable of dissolving both the collagen and the used synthetic polymer is a prerequisite. In this regard, the specialty organic solvents such as HFIP, TFE which can dissolve a wide range of polymers including those tough polymers such as polyglycolide, polyamides, polypeptides, could be the only choice as collagen is insoluble in the ordinary organic solvents. Huang et al ([@b33-ijn-2-623]) once attempted electrospinning collagen dissolved in a traditional weak acid solution. However, very high fiber-forming aiding agent PEO with a ratio of more than 50% was used. Later, with HFIP as the dissolving solvent, Matthews et al ([@b66-ijn-2-623]) successfully electrospun pure collagens into nanofibers and demonstrated the collagen's banding characteristic remains. In addition to its high polarity strong dissolving capability to various polymers, its other physical properties such as being volatile, miscible with water and many organic solvents, and low surface tension also favor it to be an ideal solvent for electrospinning. But, HFIP is a rather costly organic solvent. And there are also reports that using HFIP could modify the collagen native structure. For example, Stankus et al ([@b84-ijn-2-623]) used circular dichroism spectroscopy to evaluate the preservation of collagen secondary structure in the electrospun PEUU/collagen blends and found signs of some structural modification, in particular to those blends with collagen contents less than 50%. Previously, Doillon et al also investigated the negative influence of HFIP on the secondary structure of collagen ([@b21-ijn-2-623]). Although using the high polar HFIP is still disputable, the relatively less polar TFE could be an alternative choice of candidate solvent because TFE could facilitate reconstruction of the helical configuration of collagen ([@b5-ijn-2-623]). In another of our work on cross-linking the electrospun gelatin nanofibers, we found that the 'crystallinity' which reflects the triple-helix content was increased by about 20% ([@b99-ijn-2-623]). Despite gelatin being a denatured substance from collagen which involves rupture of the triple-helix structure by breaking the hydrogen bonds and rearranging the triple helix into a random configuration, under proper conditions, the chains are able to undergo a conformational disorder-order transition to recover the triple-helix structure ([@b72-ijn-2-623]; [@b75-ijn-2-623]). Another issue is it has been commonly found that the random blending system gave rise to a decrease in certain mechanical properties, eg, tensile strength, especially for the blending ratio of natural components up to 50% in the blending system ([@b84-ijn-2-623]; [@b31-ijn-2-623]; [@b52-ijn-2-623]; [@b101-ijn-2-623]; [@b81-ijn-2-623]). Severe phase separation and weak physical interactions between the binary blend system are probably responsible for the weakening mechanical performance ([@b101-ijn-2-623]; [@b70-ijn-2-623]; [@b99-ijn-2-623]). Mechanical properties are of crucial important in scaffold design for engineering load-bearing tissues. Electrospun nanofibers are able to emulate the nanoscale collagen in the ECM, which means matched nanomechanical properties to the cells. However, the macroscopic mechanical properties of their assembled form (eg, fibrous membranes) did not seem comparable to other types of scaffolds fabricated from the same materials. In this regard, besides optimizing the constituent ratio to minimize the decrease in mechanical properties of composite nanofibers, combination of nanofibers with other types of substrate such as microfibers and films could be a better solution for load-bearing tissue regeneration ([@b91-ijn-2-623]; [@b79-ijn-2-623]; [@b16-ijn-2-623]; [@b38-ijn-2-623]).

As mentioned before, introduction of structural proteins such as collagen (gelatin) and elastin is one of the approaches to improve the physicochemical and biological properties of the nanofibrous scaffolds. However, bioactivity of electrospun nanofibrous scaffolds can also be achieved through incorporating very tiny amount of function-regulating biomolecules such as DNA and a variety of growth factors into the scaffolds. Thereafter, they can then be released out of the scaffolds in a controlled manner to the cell microenvironment to modulate cell behavior. In such a case, the scaffold works additionally as a drug delivery functional device. For example, Luu et al demonstrated the first successful incorporation of DNA into the electrospun PLGA random copolymer and PLA-PEG block copolymer nanofibrous scaffolds for gene delivery ([@b63-ijn-2-623]). The loaded DNA was claimed to be able to be sustainably released over a period of 20 days with the scaffold still structurally intact and capable of cell transfection and bioactivity. In another study, Chew et al investigated the feasibility of encapsulating human β-nerve growth factor (NGF) in an electrospun scaffold of ɛ-caprolactone and ethyl ethylene phosphate (PCLEEP) copolymer ([@b15-ijn-2-623]). PC12 neurite outgrowth assay suggested a partial retaining of the bioactivity. Furthermore in another study, human glial cell-derived neurotrophic factor (GDNF, 0.13 wt%) was encapsulated in the PCLEEP for *in vivo* testing the efficacy of electrospun aligned protein/polymer composite fibers through a rat model for peripheral nerve-injury treatment ([@b14-ijn-2-623]). Definitely, drug-loaded composite nanofibrous scaffolds have great potential in locally controlling the cellular process. However, retention of bioactivity and realization of controlled delivery of the loaded bioactive molecules remain to be the major research interests of utilizing nanofibers. More improvements and exploration are clearly needed in this context.

Organic-inorganic blends
------------------------

For organic-inorganic blends, inorganic nanoparticles have often been incorporated into polymer matrix to add functionalities and/or to improve mechanical properties for bone tissue engineering as summarized in [Table 2](#t2-ijn-2-623){ref-type="table"}. Generally, inorganic phase such as bioactive nanoparticles nano-hydroxyapatite (nHA) ([@b49-ijn-2-623]; [@b48-ijn-2-623]; [@b55-ijn-2-623]; [@b89-ijn-2-623]; [@b94-ijn-2-623]; [@b92-ijn-2-623]), carbon nanotubes (CNT) (Saeed, [@b70-ijn-2-623]; [@b42-ijn-2-623]), nanoclays ([@b40-ijn-2-623]) and whiskers ([@b43-ijn-2-623]) have been reported for preparing nanofibrous tissue engineering scaffolds. Bone is a natural composite material which is composed of an organic matrix (mostly type I collagen) with an array of inorganic apatite nanocrystals. To mimic the bone structure, hydroxyapatite and other calcium phosphate in combination with biodegradable and biocompatible polymers are natural choices for bone tissue engineering application. [@b30-ijn-2-623] reported polycaprolactone PCL/CaCO~3~ composite nanofibers with two different PCL to calcium carbonate (CaCO~3~) ratios (PCL: CaCO~3~ 75:25 wt% and 25:75 wt%). Good cell attachment was observed for the studied composition range, which indicated a potential to utilize PCL/CaCO~3~ composite nanofibers to guide bone regeneration (GBR) membranes. Similar results were reported for composite nanofibres of hydroxyapatite nanoparticles incorporated in other polymer systems such as synthetic poly(lactic acid) ([@b48-ijn-2-623]) and natural polymers (eg, gelatin ([@b49-ijn-2-623]) and silk ([@b55-ijn-2-623])). Incorporating cell-signaling molecules such as RGD peptides and growth factors have been proven to further improve the cellular behaviour of the tissue engineering scaffolds. [@b92-ijn-2-623] reported a significant increased mineralization (55%) in PCL/nHA/Collagen biocomposite nanofibrous scaffolds after 10 days of cell culture using human fetal osteoblast cells (hFOB). They concluded that such a unique combination of nanostructures and bioactivity in nanofibrous scaffolds had inherent surface functionality for hFOB adhesion, migration, proliferation and mineralization to form a bone tissue. [@b55-ijn-2-623]) reported electrospun silk fibroin nanofibrous scaffolds containing bone morphogenetic protein 2 (BMP-2) and/or nanoparticles of hydroxyapatite for *in vitro* bone formation from human bone marrow-derived mesenchymal stem cells (hMSCs). They found that the co-existence of BMP-2 and nHA in the electrospun silk fibroin nanofibers resulted in the highest calcium deposition and upregulation of BMP-2 transcript levels when compared with other systems.

Apart from the compositions of composite nanofibers, the nano-/micro-structures and fiber morphology have also been reported to have significant effects on biological responses, which ultimately are dependent on fabrication processing. So far, most of the nanocomposites were fabricated by mixing nanoparticles with polymers using simple stirring and ultrasonification for dispersion. The particle size of nHA ranged from 10 nm to 150 nm. One of the processing related problems was the agglomeration of nanoparticles due to their large surface areas and surface interactions. The reported micro-/nano-structures of composite nanofibers had neither uniform distribution of nHA within polymer matrix nor controlled orientation and alignment of non-spheric nanoparticles such as HA nano-plates or CNTs. This not only compromises the mechanical properties but may also take a longer time to remodel into bone tissue during regeneration for such composite nanofibers in contrast to the native ECM. To overcome this problem, the interfacial forces between nanoparticles and polymers have to be carefully manipulated. [@b48-ijn-2-623] reported the use of a surfactant hydroxysteric acid (HSA) to control the interaction between the hydrophilic nHA powders and the hydrophobic chloroform-dissolved PLA. They found improved dispersability of nHA powders and resulted uniformality of composite nanofibers. However, the fiber diameters were still relatively large (1--2 μm), a common feature for electrospun fibers made from filled nanoparticles. To mimic the structures and compositions of human tissues, a biomimetic approach has to be adopted ([@b11-ijn-2-623]).

Significant progress in understanding of hierarchical structure of bone in the past decades has prompted research into how to build a scaffold that mimics the bone structure. Bone is a hierarchically structured material with remarkable mechanical properties. It is regarded as a nanocomposite material which is made up of hydroxyapatite nanocrystals and collagen over several length scales. The current approaches by utilizing nHA particles with particle sizes of tens or hundreds nanometers are far from ideal to mimic the natural bone structures where the nHA is typically platelike with a dimension of 50 × 25 × 3 nm ([@b53-ijn-2-623]). Various attempts have been carried out since the late 1990s to perform biomimetic synthesis of nHA/collagen nanocomposites and composite scaffolds ([@b4-ijn-2-623]; [@b24-ijn-2-623]). But thus far, it has failed to produce any electrospun composite nanofibers because of the processing difficulty in electrospinning of aqueous mineralised collagen system. A recent study on gelatin/HA biomimetic nanofibers was attempted to produce nanofibers for guided tissue regeneration. Kim et al ([@b49-ijn-2-623]) used a co-precipitation method to produce biomimetic gelatin/HA nanocomposite from both Ca- and P-containing gelatin solutions under alkaline condition at 40 °C. After washing and freeze drying, the co-precipitated nanocomposite was re-dissolved in a highly polar solvent, 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP). Such fluorinated alcohols have been widely used in electrospinning of natural biopolymers such as collagen ([@b66-ijn-2-623]) and gelatin ([@b101-ijn-2-623]). TEM micrographs revealed improved homogeneity over nanoparticles filled nanofibers. More importantly, the selected area electron diffraction (SAED) revealed a diffusion ring pattern on elongated HA crystals, which was characteristic of the typical apatite structure when grown in a biomimetic process where the mediation of the amino acid structure in the collagen-based organic matrix induced a preferential apatite growth along its c-axis direction ([@b47-ijn-2-623]). The disadvantages of fluorinated alcohols such as HFIP are their costs, possible toxicity and environmental concerns. The future directions in electrospinning of biomimetic nanocomposite fibers should focus on the use of more eco-friendly aqueous system which mimics more the *in vivo* cellular growth conditions of tissues.

Core-shell structured composite nanofibrous scaffolds
=====================================================

Another category of composite nanofibers is in the form of core-shell or core-sheath structure. Conventionally, a core-sheath larger sized fiber consists of a core of one type of polymer and a shell of a different polymer. The mechanical properties of the fiber are chiefly dictated by the core material, whereas the shell polymer offers external functions or properties (eg, adhesion, friction, softness). With electrospinning, core-shell structured nanofibers can be produced as well.

Coaxial electrospinning
-----------------------

Feasibility of fabricating core-shell nanofibers through a technique called coaxial electrospinning have been recently demonstrated by several research groups ([@b61-ijn-2-623]; [@b87-ijn-2-623]; [@b56-ijn-2-623]; [@b95-ijn-2-623]; [@b98-ijn-2-623]). Essentially, coaxial electrospinning is a modification or extension to the ordinary electrospinning process. The major difference is that coaxial electrospinning employs a compound spinneret which consists of one (or more) inner capillary housed by an outer tube from which different fluids are separately fed into their respective channels and integrated into a core-sheath structured composite fiber as they are charged and emitted from the compound spinneret.

With coaxial electrospinning, at least four types of functional nanofibers ([Figure 3](#f3-ijn-2-623){ref-type="fig"}) can be envisioned and actually have been demonstrated workable in the past few years. The basic fiber form is generally of concentric bi-component in morphology or surface-coating like form dependent on control of processing parameters while coaxial electrospinning two homogeneous solutions ([Figure 4a](#f4-ijn-2-623){ref-type="fig"}). If nanoparticles-containing fluid was used as core dope, nanoparticles-loaded composite nanofibers can be prepared ([Figure 4b](#f4-ijn-2-623){ref-type="fig"}). Li et al and Loscertales et al have creatively demonstrated the feasibility of directly performing one-step fabrication of hollow nanofibers ([Figure 4c](#f4-ijn-2-623){ref-type="fig"}) via combining the coaxial electrospinning and sol-gel chemistry ([@b56-ijn-2-623]; [@b62-ijn-2-623]). Furthermore, very recently Zhao et al developed multichannel microtubes ([Figure 4d](#f4-ijn-2-623){ref-type="fig"}) by extending the two-channel coaxial electrospinning approach ([@b106-ijn-2-623]) to multi-channels. Obviously, coaxial electrospinning provides a novel route to design and fabricate a variety of functional nanofiber structures.

The prospect of core-shell structured nanofibers from coaxial electrospinning looks very attractive to numerous industrial applications. However, current investigation on this technique is still quite limited and some issues such as the mechanism of forming core-shell structure and processing control on core-sheath configuration remain to be thoroughly investigated. With respect to the formation mechanism of core component, some researchers suggested that the rapid stretching of the sheath causes strong viscous stress, which will be passed onto the core fluid. The shear stress would stretch the core component and elongate it along with the sheath solution via mechanism such as viscous dragging and/or contact friction ([@b56-ijn-2-623]; [@b110-ijn-2-623]). Another issue is under what kind of conditions can high yield of core-shell structured nanofibers be produced, and how those commonly appreciated processing variables such as applied electric field strength, solution viscosity and/or concentrations, and flow rate would affect the control of sheath-thickness as well as the resultant fiber dimensions. Presently, our work indicated that by altering the inner polymer solution concentrations and flow rates, both the inner and overall diameter of coaxially electrospun bi-component nanofibers can be consequently changed ([@b98-ijn-2-623]; [@b99-ijn-2-623]). Li et al investigated the influences of varying flow rate and electrical strength. They found increasing the feeding rates led to larger inner diameter, and both the inner and outer diameters of the core-shell fibers decreased as the electrical field was enhanced.

As bioactive tissue scaffolds
-----------------------------

Coaxial electrospun core-shell structured composite nanofibers can be used for constructing bioactive cellular scaffolds by using electrospinnable bioactive macromolecules such as collagen as the shell (to impart bioactivity) and synthetic polymer as core (to retain mechanical and structural advantage). This concept and efficacy have been demonstrated in our group ([@b101-ijn-2-623]). In this work, we examined the cell proliferation and morphological differences by culturing human dermal fibroblasts (HDFs) on the collagen-r-PCL (representing collagen and PCL being the shell and core, respectively) scaffolds, and other substrates for comparison including electrospun nanofibrous scaffolds of PCL and collagen, tissue culture plate (TCP) control, and collagen-coated electrospun PCL prepared by immersing the electrospun PCL into a collagen solution overnight. After 6 days of culture, it was found that nanofibers with coatings either achieved by coaxial electrospinning or by simple immersion-coating were definitely favorable for cell proliferation. But, the efficiency is dependent on coating approaches used. Compared to pure nanofibrous PCL, the HDFs density on the core-shell nanofibrous scaffolds increased linearly by 19.5% (2 days), 22.9% (4 days), and 31.8% (6 days). In contrast, the simple immersion collagen-coated electrospun PCL increased only by 5.5% (2 days), 11.0% (4 days), and 21.0% (6 days) ([Figure 5a](#f5-ijn-2-623){ref-type="fig"}). In addition, for the PCL involved nanofibers, we also found that the HDFs could penetrate beneath the collagen-r-PCL composite nanofibers ([Figure 5b](#f5-ijn-2-623){ref-type="fig"}). However, there is no such finding either in the pristine PCL or the simple immersion collagen-coated PCL nanofibrous scaffold. This study suggests that current core-shell composite nanofibers tend to resemble the natural ECM architectural constituent of collagen, which makes cells have a propensity to interact well with them. Core-sheath nanofibers would also be a possible solution for the components-incompatible-induced limited improvement in the mechanical properties as discussed in section 2.1.

Except for coaxial electrospun core-shell nanofibers, other means such as previously used immersion coating ([@b31-ijn-2-623]; [@b101-ijn-2-623]) and chemical conjunctions ([@b17-ijn-2-623]; Ma, [@b31-ijn-2-623]; [@b48-ijn-2-623]; [@b70-ijn-2-623]; [@b10-ijn-2-623]; [@b108-ijn-2-623]) have also been attempted to make bioactive molecules coated nanofibers as summarized in [Table 3](#t3-ijn-2-623){ref-type="table"}. However, it should be noted that simple immersion coating could make the coating happened only on the shallow layer of the whole nanofibrous structure rather than on each individual fiber because of the hydrophobicity of aliphatic polyesters (eg, PLA and PCL) and nanofibrous structure contributed hydrophobic effect ([@b27-ijn-2-623]; [@b68-ijn-2-623]). For the chemical surface modification method, to have desired biomolecules conjugated on the nanofiber surface, the inert electrospun nanofibers are usually subjected to pretreatment via technique like argon plasma or UV irradiation to generate reactive species such as carboxylic or hydroxyl. This severe pretreatment would likely affect the mechanical properties of the delicate nanofibers. Furthermore, as the plasma effect only happens to a depth of several hundred angstroms, a deeper surface modification of the nanofibrous scaffold structure may be difficult to attain as well.

Delivery of bioactive molecules
-------------------------------

If drugs or bioactive agents are encapsulated by a shell polymer, core-shell electrospun nanofibers can be used for functional drug delivery. In this regard, coaxial electrospinning might be particularly suitable for making biomimetic scaffolds with drug delivery capability. The advantage is that it does not require the drug to be electrospinnable or for it to have good physicochemical interaction with the carrier polymer. In contrast, for the cases of drugs loaded by blend electrospinning, poor interaction between the drug and polymer ([@b63-ijn-2-623]; [@b96-ijn-2-623]; [@b50-ijn-2-623]; [@b97-ijn-2-623]), and drug non-electrospinnability ([@b99-ijn-2-623]) both tremendously affect the drug distribution in the polymer matrix and consequently the release behavior. The benefits of using core-shell nanofibers for such a purpose are quite obvious. Firstly, it will be able to preserve those labile biological agents such as DNA and growth factors from being deactivated or denatured even when the applying environment is aggressive. In fact, such protection begins as early as during the fabrication stage because, unlike blend electrospinning, the aqueous solution containing bioactive agents and the shell polymer solution are separately prepared and pumped through different spinning channels. This would greatly reduce the possible influence of being exposed to organic solvents. Secondly, core-shell nanofibers belong to reservoir type drug release device; therefore it will be possible to address the burst release problem noted in those electrospun fibers where drugs were usually incorporated through electrospinning a blend of the drug and polymer carrier ([@b45-ijn-2-623]; [@b109-ijn-2-623]; [@b63-ijn-2-623]; [@b50-ijn-2-623]). Furthermore, by manipulating the core-shell nano-/micro-structure, desired and controlled releasing kinetics could be achieved.

Sustainable release of proteins or drugs with core-shell nanofibers have recently been demonstrated by us and others ([@b41-ijn-2-623]; [@b34-ijn-2-623]; [@b99-ijn-2-623]). Jiang et al ([@b41-ijn-2-623]) encapsulated BSA and lysozyme in PCL nanofibers and found the released lysozyme maintained its structure and bioactivity. Huang et al coaxial electrospun Resyeratrol (RT, an antioxidant) and Gentamycin Sulfate (GS, an antibiotic) loaded nanofibers for controlled release application. In our recent work, we demonstrated the burst-release suppressing ability of core-shell nanofibers by entrapping a fluorescein-conjugated BSA in the PCL shell. These results will provide a basis for further design and optimization of processing conditions to control the core-sheath nanostructure so as to achieve highly sustainable, controllable, and effective bioactive factor releases. In the context of tissue engineering applications, as delivery of growth factors is indispensable in the course of tissue regeneration, it is believed that coaxial electrospinning and the produced core-shell nanofibers will have great potential to locally regulate cellular process for a prolonged time through controlled release of these appropriate growth factors directly into the cell living microenvironment.

Nanofibers mingled structure
============================

Mingled nanofibers refer to two (or more) different nanofibers which are concurrently electrospun to attain random and homogenous hybridization of them at individual fiber level. Besides envisioning achievable advantages in physical and mechanical properties, one of the most attractive points for the nanofibers mingled structure is that it could offer a solution to cell penetration problem associated with the electrospun nanofibrous scaffolds ([@b98-ijn-2-623]). The working principle as shown in [Figure 6](#f6-ijn-2-623){ref-type="fig"} is by simultaneously electros-pinning two kinds of biodegradable and biocompatible polymers (one of them being water soluble) to form nanofibers randomly mingled structure. From here, larger pores can then be formed *in situ* through leaching out of the water soluble nanofibers during cell culture. Formation of larger space can thus encourage cellular infiltration. This concept was also previously proposed by Kidoaki et al ([@b46-ijn-2-623]) and implemented by co-electrospinning segmented polyurethane (SPU) with poly(ethylene oxide) (PEO) to form mixed fiber mesh ([Figure 7](#f7-ijn-2-623){ref-type="fig"}). But experimental *in vitro* cell culture work to provide evidence of cell infiltration has not been attempted by anyone yet. Very recently, [@b25-ijn-2-623] simultaneously electrospun PLGA and blend of chitosan/PVA to generated mingled PLGA-chitosan/PVA composite nanofibrous scaffolds. They found such a manner of introducing chitosan/PVA component had changed the hydrophilic/hydrophobic balance, and consequently influenced degradation and mechanical properties as well as cell attachment, proliferation and migration with the nanofibrous scaffolds.

Indeed, although electrospun nanofibers can resemble the physical dimensions of the native ECM constituents, the small pores/interstices formed from nanofiber lacing of each others will be too small for cells to pass through ([@b26-ijn-2-623]; [@b46-ijn-2-623]; [@b1-ijn-2-623]; [@b73-ijn-2-623]; [@b83-ijn-2-623]). Despite the fact that numerous research works have revealed favorable cell adhesion, proliferation and phenotype preservation and functions on the electrospun nanofibrous scaffolds, supporting cellular ingrowth to form cell-scaffold integrated 3-D complex is a critical issue that needs to be resolved. After all, formation of merely a monolayer of cells on the electrospun nanofibrous scaffolds has limited application in tissue engineering. To overcome the cell infiltration problem and achieve a highly cellularized tissue engineered construct in addition to the fiber leaching methods of creating micropores or microvoids *in situ* ([@b46-ijn-2-623]; [@b101-ijn-2-623]; [@b99-ijn-2-623]), different approaches and strategies have been adopted by researchers. For instance, simultaneous electrospinning nanofibers and living cells to achieve a uniform distribution of cells through the scaffold thickness had been proposed ([@b83-ijn-2-623]). Alternatively, using coaxial electrospinning to directly produce cells-encapsulated nanofiber scaffolds is also possible to generate three dimensional distribution of cells within the electrospun scaffolds ([@b90-ijn-2-623]). Pham et al ([@b73-ijn-2-623]) electrospun PCL scaffolds consisting of alternating layers of relatively larger microfibers (2\~10 μm) and nanofibers to investigate cell infiltration.

So far, there has been work reporting cellular ingrowth to some extent ([@b66-ijn-2-623]; [@b3-ijn-2-623]; [@b84-ijn-2-623]; [@b88-ijn-2-623]; [@b101-ijn-2-623]; [@b55-ijn-2-623]). Cellular ingrowth phenomenon was explained as a result of bioactivity effect due to incorporation of bioactive components. In addition to this, appropriate nanomechanical properties of the scaffold nanofibers also allow cells to enter into the matrix through amoeboid movement to push the surrounding fibers aside to make necessary spaces. In spite of these experimental results, whether the electrospun nanofibrous scaffolds support cell infiltration is still open to debate. Systematic investigation from materials selection, manipulated geometry and physical properties of nanofibrous scaffolds, to the cell types, culture methods and conditions need to be performed. We believe while endowing nanofibers with appropriate wettability and biochemical signals would be workable for facilitating and encouraging cell migration into the scaffold interior as reported in our work and others ([@b84-ijn-2-623]; [@b88-ijn-2-623]; [@b101-ijn-2-623]; [@b1-ijn-2-623]), physical characteristics such as pore size, pore structure, pore distribution and the overall porosity of the nanofibrous scaffolds would equally play important role. Both will have direct influence on supply of the oxygen and nutrients to the cells and removal of waste products -- which are the determinant factors for cellular infiltration ([@b77-ijn-2-623]).

Concluding remarks
==================

It has been widely acknowledged in the tissue engineering research community that nanofibers produced from electrospinning technique are able to emulate the architecture of the native extracellular matrix, which is a complex fibrous network of proteins and glycosaminoglycans with hierarchical dimensions down to nanometer scale. Here, we discussed the potential of using electrospun composite nanofibers, in the form of components blended, core-shell structured, and nanofibrous mingled structures for developing biomimetic and bioactive cellular scaffolds, as well as the limitations and issues to be resolved.

In comparison to those commonly used biodegradable and biocompatible synthetic polymers, the strategy of introducing natural bioactive components into biologically inert but mechanically meritorious synthetics and converting such combinations into nanofiber form offers a facile approach to bioactivate and functionalize nanofibrous scaffolds. Because of the versatility of electrospinning, with currently established knowledge and understanding about the structure, constituents, and functions of ECM, it is conceivable that more elaborate biological recognition and signaling functions of the extracellular milieu can be integrated into the nanofibrous scaffolds for even precise recapitulation and spatiotemporal control *in vitro* and *in vivo* of the cell living environment. On the other hand, as interplays between cells and artificial scaffolds are crucial for modulating cellular functions *in vitro* and *in vivo*, the bioactive composite nanofibrous scaffolds might be an ideal biomimic platform for systematic research to enhance our understanding on cell-matrix interactions from which future design and fabrication of biomimetic nanofibrous scaffolds can be achieved and implemented in an accurate and rational manner.

It is believed endowing electrospun nanofibers bioactivity and biological functions will represent the mainstream trend in future nanofibrous scaffold related research activities. In this sense, with continual advances in electrospinning technology and biological evaluation of such scaffolds, biomimetic and bioactive composite nanofibers will be the right candidate materials in fulfilling the successful application of nanofibers in tissue engineering and regenerative medicine.

Refers to an artificial material or structure that mimics a biological material/structure/function.
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The term 'bioactive' usually refers to a material or structure that would have positive effect on the living cells *in vitro* and/or *in vivo*, due to it containing certain bioactive substances such as proteins (eg, peptides, collagens). The bioactive substances can be physically (eg, via blending) or chemically (eg, by covalently immobilization) incorporated into the material. In this paper, we define a nanofiber being bioactive if it promotes cell-scaffold interaction in terms of cellular adhesion, proliferation, migration, maintaining normal cell morphology and functions, etc.

![Schematic cross-sectional views of different structures of composite nanofibers from components of A and B. (**a**) randomly blended; (**b**) core-shell structured; and (**c**) nanofibers-mingled (from concurrent electrospinning).](ijn-2-623f1){#f1-ijn-2-623}

![SEM images of 3-D porous fibers (**a**) after gelatin was leached out of the electrospun Gt/PCL composite fibers (**b**) ([@b99-ijn-2-623]). Scale bar 2 μm.](ijn-2-623f2){#f2-ijn-2-623}

![Illustrated cross-sectional views of a variety of novel and functional polymeric nanofibers from coaxial electrospinning, including basic bi-component nanofiber, surface coated/modified nanofiber through tuning the sheath thickness, nanoparticles encapsulated nanocomposite nanofiber, and hollow nanofibers where the core component is removed.](ijn-2-623f3){#f3-ijn-2-623}

![Coaxial electrospinning were employed to develop core-shell nanofibers (**a**) ([@b98-ijn-2-623]), self-assembled FePt magnetic nanoparticles (ca. 4 nm) encapsulated nanofibers (**b**) ([@b82-ijn-2-623]), hollow nanofibers (**c**) ([@b56-ijn-2-623]), and multichannel tubes (**d**) ([@b106-ijn-2-623]).](ijn-2-623f4){#f4-ijn-2-623}

![Core-shell structured collagen-r-PCL nanofibers favored HDFs proliferation (**a**) and cellular infiltration (**b**) ([@b101-ijn-2-623]).](ijn-2-623f5){#f5-ijn-2-623}

![Schematic illustration showing the formation of larger pores by electrospinning of mingled nanofibers and in situ leaching out of the water soluble nanofibers (red lines) during cell cultivation ([@b98-ijn-2-623]).](ijn-2-623f6){#f6-ijn-2-623}

![Confocal laser scanning micrographs of electrospun mingled fibrous structure of SPU/PEO. (**a**) Bottom region of the mixed fiber mesh. SPU and PEO were stained with rhodamine and FITC, respectively. (**b**) Middle region of the mesh observed at the 4 μm-upper region than (a). (**c**) Top region of the mesh observed at the 4 μm-upper region than (**b**) ([@b46-ijn-2-623]). Scale bar 10 μm](ijn-2-623f7){#f7-ijn-2-623}

###### 

Organic--organic blend composite nanofibrous scaffolds

  **Scaffold materials**                         **Solvents used**       **Diameters of electrospun fibers**   **Cells cultured**                                        **Potential uses for tissue engineering**   **References**
  ---------------------------------------------- ----------------------- ------------------------------------- --------------------------------------------------------- ------------------------------------------- ---------------------------------------
  DNA/PLGA or PLA-- PEG block copolymer          DMF/Tris--EDTA buffer   250--875 nm, 375 nm--1.1μm            A pre--osteoblastic cell line, MC3T3E1                    Bone                                        ([@b63-ijn-2-623])
  Gelatin/PCL                                    TFE                     500--900 nm                           BMSCs, Fibroblasts                                        Skin                                        ([@b101-ijn-2-623]; [@b16-ijn-2-623])
  Collagen/PEUU                                  HFIP                    100--900 nm                           smooth muscle cells                                       Soft tissues                                ([@b84-ijn-2-623])
  Collagen/Elastin/PEO                           Aqueous HCl             220--600 nm                           SMCs                                                      Blood vessel                                ([@b6-ijn-2-623])
  PLCL/Collagen (or Heparin)                     HFIP                    120--520 nm                           HUVEC                                                     Vascular graft                              ([@b52-ijn-2-623])
  NGF--BSA/PCLEEP                                DCM/PBS                 0.5\~3.0μm                            PC12 cells                                                Nerve                                       ([@b15-ijn-2-623])
  Collagen/GAG(eg, CS)                           TFE/Water               260 nm                                RCFs                                                      /                                           ([@b107-ijn-2-623])
  Collagen/Elastin/PLGA (blend ratio 45:15:40)   HFIP                    720 ± 350 nm                          Bovine endothelial and smooth muscle cells                Vascular substitute                         ([@b85-ijn-2-623])
  Gelatin/PANi                                   HFIP                    60--800 nm                            H9c2 rat cardiac myoblast                                 Cardiac/nerve                               ([@b55-ijn-2-623])
  Gelatin/Elastin/PLGA                           HFIP                    380 ± 80 nm                           H9c2 rat cardiac myoblast, BSCs                           Heart/blood vessel                          ([@b55-ijn-2-623])
  Collagen/P(LLA--CL)                            HFIP                    100--300 nm                           HCAECs                                                    Blood vessel                                ([@b31-ijn-2-623])
  PGA/Chitin                                     HFIP                    50--350 nm                            Fibroblasts                                               /                                           ([@b70-ijn-2-623])
  PHBV/Collagen                                  HFIP                    300--600 nm                           NIH3T3                                                    /                                           ([@b67-ijn-2-623])
  PDO/Elastin                                    HFIP                    400--800 nm                           Human dermal fibroblasts                                  Vascular graft                              ([@b81-ijn-2-623])
  GDNF/PCLEEP                                    DCM/PBS                 3.96 ± 0.14μm                         *In vivo* test                                            Nerve                                       ([@b14-ijn-2-623])
  Collagen/PCL                                   HFIP                    \~275 nm                              HDFs                                                      Skin                                        ([@b93-ijn-2-623])
  Collagen/PCL (75:25)                           HFIP                    541 ± 164 nm                          Schwann cells, fibroblasts, olfactory ensheathing cells   Nerve                                       ([@b80-ijn-2-623])

**Abbreviations:** BMSC: bone marrow stromal cell; BSA, bovine serum albumin; CS, chondroitin sulfate; DCM, dichloromethane; DMF, dimethylformamide; GAG, glycos-aminoglycan; GDNF, human glial cell--derived neurotrophic factor; HCAEC, human coronary artery endothelial cell; HCl, hydrochloric acid; HDF, human dermal fibroblast; hESF, human embryo skin fibroblast; HUVEC, human umbilical vein endothelial cell; HFIP, hexafluoroisopropanol; NGF, nerve growth factor; P(LLA--CL), poly(L--lactic acid)--co--poly(ɛ--caprolactone); PANi, polyaniline; PBS, phosphate buffered saline; PCL, poly(ɛ--caprolactone); PCLEEP, polymer(ɛ--caprolactone--co--ethylethylene phosphate); PDO, polydioxanone; PEG, poly(ethylene glycol); PEO, poly(ethylene oxide); PEUU, poly(ester urethane)urea; PGA, poly(glycolic acid); PHBV, poly(3--hydroxybutyrate--co--3--hydroxyvalerate); PLA, polylactide; PLCL, poly(L--lactide--co--ɛ--caprolactone); PLGA, poly (D,L--lactide--co--glycolide); PlnDI, perlecan domain I; PVA, poly(vinyl alcohol); RCF, rabbit conjunctiva fibroblast; SMC, Smooth muscle cell; TFE, trifluoroethanol.

###### 

Organic -- inorganic blend composite nanofibrous scaffolds

  **Scaffold materials**   **Solvents**          **Diameters of electrospun fibers**   **Cells cultured**                     **Potential uses for tissue engineering**   **References**
  ------------------------ --------------------- ------------------------------------- -------------------------------------- ------------------------------------------- --------------------
  HA/Gelatin               HFIP                  200--400 nm                           human osteoblastic cells MG63          bone                                        ([@b49-ijn-2-623])
  PCL/CaCO~3~              Chloroform/Methanol   760 ± 190 nm                          human osteoblast hFOB1.19              bone                                        ([@b30-ijn-2-623])
  PHBV/HAp                 TFE                   100--2,000 nm                         COS-- 7 cells from the monkey kidney   /                                           ([@b39-ijn-2-623])
  HA/PLA                   Chloroform            1\~2 μm                               MG63 cells                             bone                                        ([@b48-ijn-2-623])
  Silk/PEO/nHAP/BMP-- 2    water                 520 ± 55 nm                           hMSCs                                  bone                                        ([@b55-ijn-2-623])
  PLLA/HA                  DCM/1,4-dioxane       \<500 nm                              human osteosarcoma MG-- 63             bone                                        ([@b19-ijn-2-623])
  PCL/HA/Collagen          HFIP                  373 ± 191 nm                          hFOB                                   bone                                        ([@b92-ijn-2-623])
  PLLA/MWCNT/HA            DCM                   250--950 nm                           DPSCs                                  dental                                      ([@b19-ijn-2-623])

**Abbreviations:** BMP-- 2, bone morphogenetic protein 2; CaCO3, calcium carbonate; DCM, dichloromethane; DPSC, dental pulp stem cell; HA/nHAP/HAp, hydroxyapatite; HFIP, hexafluoroisopropanol; hFOB, human fetal osteoblasts; hMSC, human bone marrow-- derived mesenchymal stem cell; MWCNT, multi-- wall carbon nanotube; PHBV, poly(3-- hydroxybutyrate-- co-- 3-- hydroxyvalerate); PLLA, poly(L-- lactic acid); PCL, poly(ɛ-- caprolactone); PEO, poly(ethylene oxide); PLA, polylactide; TFE, trifluoroethanol.

###### 

Core-shell structured nanofiber scaffolds

  **Scaffold materials**        **Solvents used**        **Diameters of electrospun fibers**   **Cells cultured**                    **Potential uses for tissue engineering**   **References**
  ----------------------------- ------------------------ ------------------------------------- ------------------------------------- ------------------------------------------- --------------------------
  Collagen-r-PCL                TFE                      385 ± 82 nm                           Fibroblasts                           Skin                                        ([@b101-ijn-2-623])
  Collagen-P(LLA-CL)            Aqueous HCl, DCM/DMF     470 ± 130 nm                          HCAECs                                Vascular graft                              ([@b31-ijn-2-623])
  Gelatin-\[PMAA\]-PET          TFA                      200--600 nm                           Endothelial cells                     Blood vessel                                ([@b64-ijn-2-623])
  Galactose -\[PAAc\]- PCLEEP   Acetone                  760 nm                                Hepatocytes                           Liver                                       ([@b17-ijn-2-623])
  BMP-2-\[SMCC\]-Chitosan       HFIP                     /                                     Osteoblastic MC3T3 cell               Bone                                        (Park, [@b48-ijn-2-623])
  Gelatin-\[EDAC\]-PCL          Chloroform/DMF (70:30)   200--1000 nm                          Endothelial cells                     Blood vessel                                ([@b31-ijn-2-623])
  Fibronectin-PLLC              HFIP                     100--500 nm                           Porcine esophageal epithelial cells   esophagus                                   ([@b108-ijn-2-623])
  RGD-(PLGA-b-PEG-NH2)/PLGA     DMF/THF (1:1)            449 ± 150 nm                          NIH3T3 fibroblasts                    /                                           ([@b48-ijn-2-623])
  PlnDI-collagen (or gelatin)   HFIP                     2--6 μm                               MG63 osteoblastic cells               Bone                                        ([@b10-ijn-2-623])

**Abbreviations:** BMP-2, bone morphogenetic protein-2; DCM, dichloromethane; DMF, N,N-dimethyl formamide; EDAC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride; HCAEC, human coronary artery endothelial cell; HCl, Hydrochloric acid; PAAc, poly(acrylic acid); PCL, poly(ɛ-caprolactone); PCLEEP, poly(e-caprolactone-co-ethyl ethylene phosphate); PET, poly(ethylene terephthalate); PlnDI, perlecan domain I; PLGA, poly(D,L-lactic-co-glycolic acid); PLLC, poly(L-lactide-co-caprolactone); PMAA, poly(methacrylic acid); SMCC, succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate; RGD, Arg-Gly-Asp; TFA, trifluoroacetic acid; THF, tetrahydrofuran.
